Viewing Study NCT07023861

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:56 PM
Ignite Modification Date: 2026-01-18 @ 5:52 PM
Study NCT ID: NCT07023861
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-06-17
First Post: 2025-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
Sponsor: Affiliated Hospital of Jiangnan University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Gastric Cancer (GC) View
None Urothelial Carcinoma (UC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None breast cancer View
None Gastric Cancer (GC) View
None Urothelial carcinoma (UC) View
None HER2 View
None PET/CT View
None 89Zr View